Mylan has completed its acquisition of the injectables business of Strides Arcolab, a deal worth nearly $2 billion, the drug maker said.
Indian regulators have approved a deal from Mylan to buy the injectables business of Strides Arcolab, Mylan said Tuesday.
Mylan has bought a manufacturer of generic injectables for $1.6 billion, the company said.
The Food and Drug Administration has approved a generic antibiotic made by Sagent Pharmaceuticals, Sagent said.
The Food and Drug Administration has approved a generic drug for diabetes made by Indian generic drug maker Strides Arcolab.